These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 11027144)
1. Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates. Kostrhunova H; Brabec V Biochemistry; 2000 Oct; 39(41):12639-49. PubMed ID: 11027144 [TBL] [Abstract][Full Text] [Related]
2. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. Loskotová H; Brabec V Eur J Biochem; 1999 Dec; 266(2):392-402. PubMed ID: 10561579 [TBL] [Abstract][Full Text] [Related]
3. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154 [TBL] [Abstract][Full Text] [Related]
4. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. Kasparkova J; Farrell N; Brabec V J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955 [TBL] [Abstract][Full Text] [Related]
5. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J; Novakova O; Farrell N; Brabec V Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292 [TBL] [Abstract][Full Text] [Related]
6. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Novakova O; Kasparkova J; Malina J; Natile G; Brabec V Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903 [TBL] [Abstract][Full Text] [Related]
7. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952 [TBL] [Abstract][Full Text] [Related]
8. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein. Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926 [TBL] [Abstract][Full Text] [Related]
9. Interstrand cross-links of cisplatin induce striking distortions in DNA. Malinge JM; Giraud-Panis MJ; Leng M J Inorg Biochem; 1999 Oct; 77(1-2):23-9. PubMed ID: 10626349 [TBL] [Abstract][Full Text] [Related]
10. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Brabec V; Leng M Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5345-9. PubMed ID: 8506383 [TBL] [Abstract][Full Text] [Related]
11. Fast interstrand cross-linking of cisplatin-DNA monoadducts compared with intrastrand chelation: a kinetic study using hairpin-stabilized duplex oligonucleotides. Monjardet-Bas V; Chottard JC; Kozelka J Chemistry; 2002 Mar; 8(5):1144-50. PubMed ID: 11891902 [TBL] [Abstract][Full Text] [Related]
12. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins. Mikata Y; He Q; Lippard SJ Biochemistry; 2001 Jun; 40(25):7533-41. PubMed ID: 11412107 [TBL] [Abstract][Full Text] [Related]
14. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups. Brabec V; Neplechova K; Kasparkova J; Farrell N J Biol Inorg Chem; 2000 Jun; 5(3):364-8. PubMed ID: 10907747 [TBL] [Abstract][Full Text] [Related]
15. Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin. Teuben JM; Bauer C; Wang AH; Reedijk J Biochemistry; 1999 Sep; 38(38):12305-12. PubMed ID: 10493798 [TBL] [Abstract][Full Text] [Related]
16. Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. Hofr C; Brabec V J Biol Chem; 2001 Mar; 276(13):9655-61. PubMed ID: 11104778 [TBL] [Abstract][Full Text] [Related]
17. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899 [TBL] [Abstract][Full Text] [Related]
18. Reaction of a biscationic distamycin-ellipticine hybrid ligand with DNA. Mode and sequence specificity of binding. Bailly C; Michaux C; Colson P; Houssier C; Sun JS; Garestier T; Hélène C; Hénichart JP; Rivalle C; Bisagni E Biochemistry; 1994 Dec; 33(51):15348-64. PubMed ID: 7803398 [TBL] [Abstract][Full Text] [Related]
19. NMR solution structure of a DNA dodecamer containing a transplatin interstrand GN7-CN3 cross-link. Paquet F; Boudvillain M; Lancelot G; Leng M Nucleic Acids Res; 1999 Nov; 27(21):4261-8. PubMed ID: 10518619 [TBL] [Abstract][Full Text] [Related]
20. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. Malina J; Natile G; Brabec V Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]